TYLER, Texas—ENvue Medical, Inc., a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and homecare settings, announced the launch of a development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes.
Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwelling NG tubes are commonly associated with nasal and throat discomfort during the dwell phase, an issue for which limited mitigation options currently exist.
The program builds on previously published, peer-reviewed clinical research demonstrating that surface acoustic wave micro-vibration technology applied to nasogastric tubes can reduce friction at the tube–tissue interface during indwelling use.
“We believe that this program represents a disciplined platform expansion initiative focused on improving the overall enteral care experience by addressing patient comfort during prolonged NG tube use," said Doron Besser, CEO of ENvue Medical. "While this initiative is exploratory in nature and does not represent a commercial product launch or regulatory clearance announcement, we believe the data will be invaluable for our ongoing commercial efforts of our technology.”
Besser continued this program reflects ENvue's strategy of responsibly extending the ENvue platform to address clinically meaningful aspects of patient experience using validated technology it already owns.
The company said the integration program will focus on technical feasibility, clinical pathway assessment and regulatory and quality considerations to determine how vibration-based comfort technology could be incorporated into ENvue’s broader enteral ecosystem in the future.